Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 19, 2017 21:46 ET | Source: Neos Therapeutics, Inc

Neos Therapeutics Announces FDA Approval of Cotempla XR-ODT™ (methylphenidate) Extended-Release Orally Disintegrating Tablets for the Treatment of ADHD in Patients 6 to 17 Years Old

DALLAS and FORT WORTH, Texas, June 19, 2017 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (Nasdaq:NEOS), a pharmaceutical company focused on developing, manufacturing and commercializing innovative...
June 14, 2017 07:30 ET | Source: Neos Therapeutics, Inc

Neos Therapeutics to Present at the JMP Securities 2017 Life Sciences Conference

DALLAS/FORT WORTH, Texas, June 14, 2017 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (NASDAQ:NEOS), a pharmaceutical company focused on developing, manufacturing and commercializing innovative...
May 30, 2017 07:30 ET | Source: Neos Therapeutics, Inc

Neos Therapeutics to Present at Jefferies 2017 Global Healthcare Conference

DALLAS and FORT WORTH, Texas, May 30, 2017 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (NASDAQ:NEOS), a pharmaceutical company focused on developing, manufacturing and commercializing innovative...
May 16, 2017 07:30 ET | Source: Neos Therapeutics, Inc

Neos Therapeutics to Present at 2017 UBS Global Healthcare Conference

DALLAS and FORT WORTH, Texas, May 16, 2017 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (NASDAQ:NEOS), a pharmaceutical company focused on developing, manufacturing and commercializing innovative...
May 09, 2017 07:00 ET | Source: Neos Therapeutics, Inc

Neos Therapeutics Reports First Quarter 2017 Financial Results

DALLAS and FORT WORTH, Texas, May 09, 2017 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (NASDAQ:NEOS), a pharmaceutical company focused on developing, manufacturing and commercializing innovative...
May 02, 2017 07:30 ET | Source: Neos Therapeutics, Inc

Neos Therapeutics to Host First Quarter 2017 Financial Results Conference Call on May 9, 2017

DALLAS and FORT WORTH, Texas, May 02, 2017 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (NASDAQ:NEOS), a pharmaceutical company focused on developing, manufacturing and commercializing innovative...
March 14, 2017 07:00 ET | Source: Neos Therapeutics, Inc

Neos Therapeutics Reports Fourth Quarter and Full Year 2016 Financial Results

DALLAS and FORT WORTH, Texas, March 14, 2017 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (NASDAQ:NEOS), a pharmaceutical company focused on developing, manufacturing and commercializing innovative...
March 08, 2017 07:30 ET | Source: Neos Therapeutics, Inc

Neos Therapeutics to Host Fourth Quarter and Year-End 2016 Financial Results Conference Call on March 14, 2017

DALLAS and FORT WORTH, Texas, March 08, 2017 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (NASDAQ:NEOS), a pharmaceutical company focused on developing, manufacturing and commercializing innovative...
February 28, 2017 07:30 ET | Source: Neos Therapeutics, Inc

Neos Therapeutics to Present at the Cowen and Company 37th Annual Health Care Conference

DALLAS and FORT WORTH, Texas, Feb. 28, 2017 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (NASDAQ:NEOS), a pharmaceutical company focused on developing, manufacturing and commercializing innovative...
February 16, 2017 07:30 ET | Source: Neos Therapeutics, Inc

Neos Therapeutics to Present at the RBC Capital Markets 2017 Global Healthcare Conference

DALLAS and FORT WORTH, Texas, Feb. 16, 2017 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (NASDAQ:NEOS), a pharmaceutical company focused on developing, manufacturing and commercializing innovative...

keyboard_arrow_left Previous Page

Next Page keyboard_arrow_right